Sage Journals: Discover world-class research

Abstract

Background

Percutaneous therapy with various sclerosants is an established treatment of venous malformations in general. We investigated the safety and effectiveness of polidocanol in the craniofacial region.

Purpose

To present and evaluate our subjective and objective mid- and long-term results of patients with craniofacial venous malformations (CFVM) after percutaneous sclerotherapy using polidocanol.

Material and Methods

Twenty patients with CFVM treated by percutaneous sclerotherapy were followed up and asked to fill in a questionnaire comparing levels of the following CFVM-related symptoms before and after treatment: pain; functional impairment; cosmetic deformities; and impairment in daily life. Additionally, both size reduction as well as procedural-related complication rates were analyzed.

Results

Evaluation of the questionnaire revealed an improvement or complete relief of CFVM-related symptoms with significant reduced impairment in daily life after percutaneous sclerotherapy. Eighteen (90%) patients noticed a post-sclerotherapy improvement of at least one of their corresponding symptoms and expressed satisfaction with regard to their treatment. For 13 patients, a > 50% size reduction of the CFVM could be observed, while seven exhibited a < 50% size reduction. One minor complication was encountered in 56 treatment sessions (1.8%).

Conclusion

Percutaneous sclerotherapy using polidocanol is a well-tolerated treatment for CFVM with a low complication rate. Size reduction and positive results with improvement of different clinical symptoms can be achieved.

Keywords

Face vascular veins head/neck sclerotherapy polidocanol

Get full access to this article

View all access options for this article.

References

Lasjaunias

Berenstein

TerBrugge

KG.

Surgical neuroangiography; clinical and interventional aspects in children. Berlin, Heidelberg, New York: Springer Verlag, 2006.

Persky

Yoo

Berenstein

Management of vascular malformations of the mandible and maxilla.

Laryngoscope 2003; 113:1885–1892.

Niimi

Song

Berenstein

Current endovascular management of maxillofacial vascular malformations.

Neuroimaging Clin N Am 2007; 17:223–237.

Agid

Burvin

Gomori

Sclerotherapy for venous malformations using a “negative subtraction” technique.

Neuroradiology 2006; 48:127–129.

Burrows

PE.

Endovascular treatment of slow-flow vascular malformations.

Tech Vasc Interv Radiol 2013; 16:12–21.

Puig

Aref

Chigot

et al . Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 2003; 33:99–103.

Flors

Leiva-Salinas

Maged

et al . MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 2011; 31:1321–1340.

Herborn

Goyen

Lauenstein

et al . Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol 2003; 181:729–735.

Wassef

Blei

Adams

et al . ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136:e203–214.

10.

Aboelatta

Naqy

Shaker

et al . Venous malformations of the head and neck: a diagnostic approach and a proposed management approach based on clinical, radiological, and histopathology findings. Head Neck 2014; 36:1052–1057.

11.

Brassel

Meila

Evolution of embolic agents in interventional neuroradiology.

Clin Neuroradiol 2015; 25 (Suppl. 2):333–339.

12.

Qiu

Chen

Lin

et al . Outcomes and complications of sclerotherapy for venous malformations. Vasc Endovascular Surg 2013; 47:454–461.

13.

Park

et al . Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulphate sclerotherapy of venous malformations. Eur Radiol 2016; 26:1301–1310.

14.

Ali

Weiss

Sinha

et al . The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology 2016; 31:603–609.

15.

Spence

Krings

TerBrugge

et al . Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 2011; 33:125–130.

16.

Rautio

Laranne

Kähärä

et al . Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol 2004; 45:738–745.

17.

Alakailly

Kummoona

Quereshy

et al . The use of sodium tetradecyl sulphate for the treatment of venous malformations of the head and neck. J Maxillofac Oral Surg 2015; 14:332–338.

18.

Blaise

Charavin-Cocuzza

Riom

et al . Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg 2011; 41:412–417.

19.

Bowman

Johnson

McKusick

et al . Outcomes of sclerotherapy and embolization for arteriovenous and venous malformations. Semin Vasc Surg 2013; 26:48–54.

20.

Meila

Grieb

Greling

et al.

Endovascular treatment of head and neck arteriovenous malformations: long-term angiographic and quality of life results. J Neurointerv Surg 2017; 9:860–866.

21.

Van der Linden

Pattynama

Heeres

et al . Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. Radiology 2009; 251:926–932.

Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience

Abstract

Background

Purpose

Material and Methods

Results

Conclusion

Keywords

Get full access to this article

References